Baxter International Inc. (BAX)
Smart-money score is below the middle; business numbers score is on the low side, price trend score is above the middle.
BAX scores higher than 61% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Baxter International Inc. (BAX) scores 47 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.47× 30-day average
- 52-week range
- 15.73 – 30.00
- Market cap
- $11.79B
- Earnings date
- 29 Oct 2026
- Dividend yield
- 3.22%
- Volume
- 3,011,403
- Avg. volume (30d)
- 6,425,566
- Open
- 23.93
- Previous close
- 23.90
- Day's range (regular session)
- 23.84 – 24.46
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.67
- P/E (TTM)
- —
- EPS (TTM)
- -2.07
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for BAX
- 3 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for BAX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about BAX right now
Baxter International Inc. (BAX) currently scores 47/100 on the Market Census six-factor composite, at the Average score level. BAX is +1.88% on the day and +3.49% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in BAX's data roughly balance out right now. BAX's strongest factor is price trend at 75/100 — a strong read on which way the price has been going. The weakest factor is insider trades at 10/100 — a well below average read on insider buying and selling. Insider filings for BAX lean toward selling; on a thinly filed name a few filings can set this reading.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See BAX in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent BAX news
Latest headlines that name Baxter International, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Baxter to Host Third-Quarter 2026 Financial Results Conference Call for InvestorsYahoo
- What Investors Might Be Missing On Baxter International (BAX)Yahoo
- Baxter Releases Inaugural Connected Hospital ReportYahoo
- Is Baxter Stock Underperforming the Nasdaq?Yahoo
- Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeekingAlpha
We hide 6 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to BAX’s 47, all within 1 point.
Sorted by closeness to BAX’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.